EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study)

被引：0

作者：

Jun, Ji Eun ^{[1
]}

Choi, Sung Hee ^{[2
]}

Moon, Min Kyong ^{[3
]}

Ko, Seung-Hyun ^{[4
]}

Kim, Hae Jin ^{[5
]}

Hur, Kyu Yeon ^{[6
]}

Rhee, Eun-Jung ^{[7
]}

Noh, Jung Hyun ^{[8
]}

Jeong, In-Kyung ^{[1
]}

机构：

[1] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Internal Med, Div Endocrinol & Metab,Sch Med, 892 Dongnam Ro, Seoul 05278, South Korea

[2] Seoul Natl Univ, Coll Med, Bundang Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea

[3] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea

[4] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab,St Vincents Hosp, Seoul, South Korea

[5] Ajou Univ, Sch Med, Dept Endocrinol & Metab, Suwon, South Korea

[6] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea

[7] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea

[8] Inje Univ, Ilsan Paik Hosp, Dept Med, Div Endocrinol & Metab,Coll Med, Goyang, South Korea

来源：

DIABETES OBESITY & METABOLISM | 2025年

关键词：

antidiabetic drug; DPP-IV inhibitor; randomized trial; insulin resistance; type; 2; diabetes; BASAL;

D O I：

10.1111/dom.16557

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 10 条

[1] Weight gain and insulin requirement in type 2 diabetic patients during the first year after initiating insulin therapy dependent on baseline BMI [J].

Biesenbach, G. ;

Raml, A. ;

Alsaraji, N. .

DIABETES OBESITY & METABOLISM, 2006, 8 (06) :669-673

[2] The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose [J].

Bock, Gerlies ;

Man, Chiara Dalla ;

Micheletto, Francesco ;

Basu, Rita ;

Giesler, Paula D. ;

Laugen, Jeanette ;

Deacon, Carolyn F. ;

Holst, Jens J. ;

Toffolo, Gianna ;

Cobelli, Claudio ;

Rizza, Robert A. ;

Vella, Adrian .

CLINICAL ENDOCRINOLOGY, 2010, 73 (02) :189-196

[3] Efficacy of dipeptidyl-peptidase-4 inhibitors and impact on β-cell function in Asian and Caucasian type 2 diabetes mellitus patients: A meta-analysis [J].

Cai, Xiaoling ;

Han, Xueyao ;

Luo, Yingying ;

Ji, Linong .

JOURNAL OF DIABETES, 2015, 7 (03) :347-359

[4] Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios [J].

Gomez-Peralta, Fernando ;

Abreu, Cristina ;

Gomez-Rodriguez, Sara ;

Barranco, Rafael J. ;

Umpierrez, Guillermo E. .

DIABETES THERAPY, 2018, 9 (05) :1775-1789

[5] Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes [J].

Holman, Rury R. ;

Thorne, Kerensa I. ;

Farmer, Andrew J. ;

Davies, Melanie J. ;

Keenan, Joanne F. ;

Paul, Sanjoy ;

Levy, Jonathan C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (17) :1716-1730

[6] Therapeutic Effects of Switching to Anagliptin from Other DPP-4 Inhibitors in T2DM Patients with Inadequate Glycemic Control: A Non-interventional, Single-Arm, Open-Label, Multicenter Observational Study [J].

Kim, Sang-Yong ;

Kim, Sungrae .

DIABETES THERAPY, 2023, 14 (01) :109-121

[7] Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability [J].

Nishio, Shinya ;

Abe, Mariko ;

Ito, Hiroyuki .

DIABETES METABOLIC SYNDROME AND OBESITY, 2015, 8 :163-171

[8] Sitagliptin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus [J].

Plosker, Greg L. .

DRUGS, 2014, 74 (02) :223-242

[9] Contributions of Basal and Postprandial Hyperglycemia Over a Wide Range of A1C Levels Before and After Treatment Intensification in Type 2 Diabetes [J].

Riddle, Matthew ;

Umpierrez, Guillermo ;

DiGenio, Andres ;

Zhou, Rong ;

Rosenstock, Julio .

DIABETES CARE, 2011, 34 (12) :2508-2514

[10] Dipeptidyl peptidase-4 inhibitor and insulin combination treatment in type 2 diabetes and chronic kidney disease: A meta-analysis [J].

Zhou, Xianling ;

Shi, Heng ;

Zhu, Shiping ;

Wang, Haixia ;

Sun, Shengyun .

JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (03) :468-477

← 1 →